TNSN96016A1 - Utilisation de phenylcyclohexylcarboxamides - Google Patents
Utilisation de phenylcyclohexylcarboxamidesInfo
- Publication number
- TNSN96016A1 TNSN96016A1 TNTNSN96016A TNSN96016A TNSN96016A1 TN SN96016 A1 TNSN96016 A1 TN SN96016A1 TN TNSN96016 A TNTNSN96016 A TN TNSN96016A TN SN96016 A TNSN96016 A TN SN96016A TN SN96016 A1 TNSN96016 A1 TN SN96016A1
- Authority
- TN
- Tunisia
- Prior art keywords
- phenylcyclohexylcarboxamides
- medicinal products
- restenosis
- treatment
- active ingredients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LES PHENYLCYCLOHEXYLCARBOXAMIDES, DONT QUELQUES UNS SONT CONNUS, CONVIENNENT COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS, EN PARTICULIER DANS DES MEDICAMENTS DESTINES AU TRAITEMENT DE LA RESTENOSE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19503160A DE19503160A1 (de) | 1995-02-01 | 1995-02-01 | Verwendung von Phenylcyclohexylcarbonsäureamiden |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN96016A1 true TNSN96016A1 (fr) | 2005-03-15 |
Family
ID=7752849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN96016A TNSN96016A1 (fr) | 1995-02-01 | 1996-02-01 | Utilisation de phenylcyclohexylcarboxamides |
Country Status (31)
Country | Link |
---|---|
US (1) | US5935983A (fr) |
EP (1) | EP0725064A1 (fr) |
JP (1) | JPH08253453A (fr) |
KR (1) | KR960031442A (fr) |
CN (1) | CN1137380A (fr) |
AR (1) | AR002272A1 (fr) |
AU (1) | AU710235B2 (fr) |
BG (2) | BG63044B1 (fr) |
CA (1) | CA2168317A1 (fr) |
CZ (1) | CZ29196A3 (fr) |
DE (1) | DE19503160A1 (fr) |
DZ (1) | DZ1986A1 (fr) |
EE (1) | EE9600023A (fr) |
FI (1) | FI960425A (fr) |
HR (1) | HRP960017A2 (fr) |
HU (1) | HUP9600227A3 (fr) |
IL (1) | IL116931A (fr) |
MA (1) | MA23794A1 (fr) |
NO (1) | NO309841B1 (fr) |
NZ (1) | NZ280905A (fr) |
PL (1) | PL312546A1 (fr) |
RO (1) | RO117256B1 (fr) |
RU (1) | RU2158261C2 (fr) |
SG (1) | SG42329A1 (fr) |
SK (1) | SK13796A3 (fr) |
SV (1) | SV1996000008A (fr) |
TN (1) | TNSN96016A1 (fr) |
TW (1) | TW448176B (fr) |
UA (1) | UA35623C2 (fr) |
YU (1) | YU5896A (fr) |
ZA (1) | ZA96725B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911462B2 (en) * | 1998-05-22 | 2005-06-28 | Avanir Pharmaceuticals | Benzimidazole compounds for regulating IgE |
DE19924818A1 (de) * | 1999-05-29 | 2000-11-30 | Bayer Ag | Substituierte Phenylcyclohexancarbonsäureamide |
DE19924819A1 (de) * | 1999-05-29 | 2000-11-30 | Bayer Ag | Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) |
RU2003127367A (ru) * | 2001-03-12 | 2005-03-20 | Аванир Фармасьютиклз (Us) | Бензимидазоловые соединения для модулирования ige и ингибирования клеточной пролиферации |
DE10150310A1 (de) * | 2001-10-11 | 2003-04-24 | Bayer Ag | Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung |
US6934951B2 (en) | 2002-01-17 | 2005-08-23 | Intel Corporation | Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section |
TW200304820A (en) * | 2002-03-25 | 2003-10-16 | Avanir Pharmaceuticals | Use of benzimidazole analogs in the treatment of cell proliferation |
TW200400040A (en) * | 2002-05-17 | 2004-01-01 | Wyeth Corp | Hormone replacement therapy |
AU2003270426A1 (en) | 2002-09-12 | 2004-04-30 | Avanir Pharmaceuticals | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
TWI276631B (en) * | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
AU2004263190A1 (en) * | 2003-08-08 | 2005-02-17 | Avanir Pharmaceuticals | Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4226109A1 (de) * | 1992-08-07 | 1994-02-10 | Bayer Ag | Verwendung von ASS zur Hemmung von Plaquebildung |
DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
US5358959A (en) * | 1993-02-18 | 1994-10-25 | President And Fellows Of Harvard University | Methods for treating arteriosclerosis |
DE4401893A1 (de) * | 1994-01-24 | 1995-07-27 | Bayer Ag | Substituierte Arylharnstoffe |
-
1995
- 1995-02-01 DE DE19503160A patent/DE19503160A1/de not_active Withdrawn
-
1996
- 1996-01-15 HR HR19503160.1A patent/HRP960017A2/hr not_active Application Discontinuation
- 1996-01-19 EP EP96100760A patent/EP0725064A1/fr not_active Withdrawn
- 1996-01-22 AR ARP960101106A patent/AR002272A1/es not_active Application Discontinuation
- 1996-01-22 TW TW085100684A patent/TW448176B/zh active
- 1996-01-26 RO RO96-00152A patent/RO117256B1/ro unknown
- 1996-01-29 JP JP8033174A patent/JPH08253453A/ja active Pending
- 1996-01-29 IL IL11693196A patent/IL116931A/xx not_active IP Right Cessation
- 1996-01-29 NZ NZ280905A patent/NZ280905A/en unknown
- 1996-01-29 CA CA002168317A patent/CA2168317A1/fr not_active Abandoned
- 1996-01-30 YU YU5896A patent/YU5896A/sh unknown
- 1996-01-30 UA UA96010375A patent/UA35623C2/uk unknown
- 1996-01-30 BG BG100326A patent/BG63044B1/bg unknown
- 1996-01-30 FI FI960425A patent/FI960425A/fi unknown
- 1996-01-30 PL PL96312546A patent/PL312546A1/xx unknown
- 1996-01-30 AU AU42240/96A patent/AU710235B2/en not_active Ceased
- 1996-01-30 BG BG103820/99A patent/BG103820A/bg unknown
- 1996-01-31 ZA ZA96725A patent/ZA96725B/xx unknown
- 1996-01-31 RU RU96101800/04A patent/RU2158261C2/ru active
- 1996-01-31 CZ CZ96291A patent/CZ29196A3/cs unknown
- 1996-01-31 DZ DZ960027A patent/DZ1986A1/fr active
- 1996-01-31 EE EE9600023A patent/EE9600023A/xx unknown
- 1996-01-31 KR KR1019960002344A patent/KR960031442A/ko not_active Application Discontinuation
- 1996-01-31 NO NO960414A patent/NO309841B1/no not_active IP Right Cessation
- 1996-01-31 SK SK137-96A patent/SK13796A3/sk unknown
- 1996-02-01 HU HU9600227A patent/HUP9600227A3/hu unknown
- 1996-02-01 SV SV1996000008A patent/SV1996000008A/es unknown
- 1996-02-01 MA MA24149A patent/MA23794A1/fr unknown
- 1996-02-01 TN TNTNSN96016A patent/TNSN96016A1/fr unknown
- 1996-02-01 CN CN96102574A patent/CN1137380A/zh active Pending
- 1996-02-01 SG SG1996000776A patent/SG42329A1/en unknown
-
1997
- 1997-10-24 US US08/960,075 patent/US5935983A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO962088L (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
FI956014A (fi) | Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon | |
EE05074B1 (et) | Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
WO2002085299A3 (fr) | Traitements therapeutiques recourant a l'application directe de compositions metalliques antimicrobiennes | |
DE69331739T2 (de) | Neuartige pharmazeutische verwendungen von krill-enzymen | |
PL331709A1 (en) | Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
MX9602973A (es) | Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida. | |
WO2003100574A3 (fr) | Appareils d'orthodontie et systemes et procedes de distribution d'appareils d'orthodontie | |
TNSN96016A1 (fr) | Utilisation de phenylcyclohexylcarboxamides | |
ME00578A (en) | Use of gastrointestinal lipase inhibitors | |
SI1492773T1 (sl) | 4-(heterociklil)-benzensulfoksiminske spojine za zdravljenje vnetja | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
DE69521122T2 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
MX9803610A (es) | Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico. | |
HUP0204208A2 (hu) | Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény | |
GB9505082D0 (en) | Medicament | |
HK1050203A1 (en) | Novel fusidic acid derivatives. | |
AU2002234644A1 (en) | Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |